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Articular cartilage, together with skin, was predicted to be one of the first tissues to 
be successfully engineered. However cartilage repair remains nowadays still elusive, as 
we are still not able to overcome the hurdles of creating biomaterials corresponding 
to the native properties of the tissue, and which operate in joints environment that 
is not favorable for regeneration. In this review, we give an overview of the outcome 
of current cartilage treatment techniques. Furthermore we present current research 
strategies for improving cartilage tissue engineering.
Keywords:?????????? ????????????????????????????????? ????????????????????????????? 
??????????
Articular cartilage focal lesion following 
a recreational activity such as football is a 
very common event that repeats thousands 
of times every week-end around the world. 
As illustration, the analysis of 25,124 knee 
arthroscopies performed from 1989 to 2004 
in two Polish centers has revealed cartilage 
lesions in 60% of the patients [1], with more 
than 40% that were due to football injuries 
(Figure 1). In a review of 993 arthroscopies, 
localized cartilage defects were found in 20% 
of the knees in patients with a mean age of 
35 years, showing thus a significant incidence 
in young adult population [2]. It has also been 
reported that 5% of 31,516 knee arthrosco-
pies diagnosed full-thickness cartilage lesions 
for patients under 40 years of age [3]. It is also 
notable to mention that a non-negligible per-
centage of cartilage lesions is asymptomatic, 
as it has been diagnosed for 5–10% of NBA 
players [4].
Despite diverse approaches, nowadays 
there is no treatment able to restore hyaline-
like cartilage with native tissue characteristics 
(Figure 2), which consists of an extracellu-
lar matrix (ECM) composed of water (70 to 
80%), collagen (50 to 75% of dry weight) and 
glycosaminoglycans (GAGs) (15 to 30% of 
dry weight) [5]. This ECM composition con-
fers cartilage functional viscoelastic properties 
able to sustain the specific compressive, ten-
sile and frictional properties of the joint bio-
mechanics [6]. Actually, the articular surface 
regeneration still remains a challenge because 
no long-term satisfactory results have been 
obtained so far with any of the available tech-
niques used to treat knee lesions [7,8]. The low 
capacity of regeneration of the tissue is mainly 
due to its avascular and alymphatic nature [9].
We aim to present in this review different 
technological strategies to improve cartilage 
repair based on the clinical outcomes of the 
current treatment techniques. The objec-
tive of this review is to highlight the current 
concepts on biomaterials, biomechanics, 
tissue engineering and the actual vision for 
improving the surgical techniques.
Current cartilage repair techniques
There are two types of articular cartilage 
lesions that can be identified: degenerative 
arthritis, also called osteoarthritis (OA), 
which is a disease initiated by the loss of 
proteoglycans from the extracellular matrix 
and a disruption of the collagenous network 
therein [11]; and traumatic lesions, which are 
referred to as an articular cartilage injury or 
chondral injury (Table 1).
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Figure 1. Percentage of knee injury caused by sport 
activities.  
Reproduced with permission from [1]. 
For color figures, please see online at www.
futuremedicine.com/doi/full/10.2217/NNM.15.119
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Figure 2. Illustration of articular cartilage showing the distribution and morphology of chondrocytes in the 
different zones of cartilage, as well as the organization of collagen fibers.  
Reproduced with permission from [10].
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In case of a traumatic lesion, clinicians grade the sever-
ity and complexity of articular cartilage defect based on 
the depth of the injury [12,13], and as classified by the 
International Cartilage Repair Society (ICRS; www.car-
tilage.org/). Grade I is very mild with softening; Grade 
II includes fissuring or crater depth less than half the full 
thickness; Grade III is a deep defect that is through most 
of the thickness of the cartilage; and the most severe, 
Grade IV is a full thickness defects with exposed bone. 
Higher-grade lesions (III or IV) can have major negative 
impact on a person’s mobility and life quality. Usually 
with time, a traumatic lesion leads to OA, though the 
precise pathophysiology is not yet fully understood [14,15].
There are currently three surgical techniques for the 
repair of articular cartilage (Figure 3). The first surgi-
cal technique is commonly called microfracture (MF). 
This method was initially developed by Priddie in 1959 
and it implies the access to the bone marrow spaces 
by drilling, which promotes blood clot formation [16]. 
Then the evolution to microfracturing was introduced 
by Steadman et al. in 1994 [17]. This procedure is also 
called marrow stimulation, as access to bone marrow 
is given to allow the mesenchymal stem cells (MSCs) 
to migrate to repair the defect. The second surgical 
technique is the autologous chondrocytes implantation 
(ACI), which was tried for the first time by Brittberg et 
al. in 1994 [18]. As indicated by its name, ACI implies 
a subsequent chondrocyte reinjection after biopsy of a 
nonload-bearing area of cartilage and ex vivo cell expan-
sion. The third surgical technique is mosaicplasty or 
osteochondral autograft transfer, which involves the 
surgical transfer of mature autologous tissue from non-
loading-bearing region to a cartilage defect [19,20]. This 
procedure usually concerns cases where subchondral 
bone is also affected. Likewise, allografts are also used 
in clinics for osteochondral defects [21].
The main limitation of the MF and ACI is that the 
newly formed tissue lacks the structural organization 
of collagen network and other ECM components, spe-
cially in patients over 50 years old, probably because 
either the MSCs or autologous chondrocytes suffer an 
age-related loss in their potential to proliferate and dif-
ferentiate [23,24]. Consequently, the neoformed tissue 
is fibrocartilaginous having inferior quality compared 
with native tissue and is thus disposed to failure [6]. 
Nevertheless, MF or ACI techniques allow to close the 
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lesion, to give congruency to the tissue and to reduce 
the pain, but it is not clear yet if it can reduce the risk 
of OA development [25].
Lately, several systematic reviews have been pub-
lished on the comparison of ACI with the two other 
surgical techniques [26–30]. These reviews could not 
conclude on the superiority of ACI over MF and osteo-
chondral autograft transfer. Nevertheless, Harris et al. 
have highlighted that in defects larger than 4 cm2 better 
outcomes can be expected with ACI, suggesting a treat-
ment depending on the size and severity of the defect 
(Figure 4). Over 5 years follow-up, no matter which sur-
gical technique has been used, the clinical result is the 
same and no significant difference remains in the out-
comes that is dependent to the size of the defect. In four 
randomized studies, it has been shown that age is also a 
parameter that most influenced the cartilage repair, as 
young patients under the age of 30 years appear to have 
a better healing independently of the surgery technique 
compared with patients over the age of 30 years [31].
It has been shown that MF would have a deleterious 
impact on posterior ACI intervention [32], suggesting 
thus that it is important to find from the beginning the 
most appropriate surgical technique to treat cartilage 
defects.
Clinical products for cartilage repair
Cell-based products
The ACI initial technique, where a periosteal flap is 
used to maintain the transplanted chondrocytes, is the 
only technique that is US FDA-approved [33]. While it 
has shown favorable results with 73.5% success at mean 
12.8 years post surgery [34], remain the issue of 30% 
periosteum hypertrophy and a limitation to lesions 
small in size (average defect size 5.2 cm2). This post-
operative complication led to the development of mem-
branes as substitutes to the periosteal flaps. This tech-
nology evolved into a second-generation ACI also called 
matrix assisted chondrocytes implantation (MACI) 
procedure. The advantages of using a matrix instead 
of a periosteum flap are that it mimics in vivo condi-
tions, avoids the periosteum preparation and allows the 
migration of cells into the matrix, as well as it allows the 
treatment of larger lesions with less transplant hypertro-
phy [35]. The different products offered by companies 
and used in clinics are reported in Table 2.
The main disadvantages of a cell-based approach are 
that first the harvesting step remains in the case of an 
autologous implantation, and second the cell culture 
is time consuming, very expensive and induces cell 
dedifferentiation [36]. Also, a clear age-dependency on 
chondrocytes activity has been observed [37] produc-
ing then an inherent variability in the treatment out-
come. Alternatively, allogeneic cells such as MSCs can 
be used, but the utility of those latter remains limited 
due to cells stability and hypertrophy issues (Table 3).
No clinical difference between an ACI or MACI 
techniques has been shown yet [38], but as multiple 
matrices were considered in the study it was difficult to 
compare the results.
Scaffolds
In order to circumvent the limitations of cell-based pro-
cedures, several companies offer to use acellular scaf-
folds to treat the cartilage defects (Table 4). The idea is 
to promote the activity of the endogenous progenitor 
cells by combining those scaffolds with original micro-
fracture technique [39]. Thus, cells migrate through the 
scaffold, which structurally stabilize the clot to initiate 
a more robust repair response when compared with MF 
alone [40]. This process is commonly called autologous 
matrix-induced chondrogenesis (AMIC). The advan-
Table 1. Classification of chondral lesions according to the International Cartilage Repair Society 
system.
Cartilage status Grade Description
Normal 0 Healthy cartilage
Almost normal 1a Superficial lesions/softening
 1b As in 1a and/or superficial cracks or fissures
Abnormal 2 Extent <50% of thickness
Severe lesion 3a Extent >50%
 3b Down to the calcified layer
 3c Down to the surface of the subchondral bone (without penetration)
 3d Includes budging of the cartilage around the lesion
Very severe lesion 4a Penetration of the subchondral bone but not across the entire diameter of 
the defect
 4b Penetration across the full diameter of the defect
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Figure 3. Surgical techniques to treat cartilage. (A) Cartilage repair with the microfracture technique involving 
several steps that include the debridement to a stable cartilage margin, the careful removal of the calcified 
cartilage layer and the homogeneous placement of microfracture penetrations within the cartilage defect, 
with resultant complete defect fill by a well-anchored mesenchymal clot. Reproduced with permission from [22]. 
(B) Diagram of autologous chondrocytes implantation in the right condyle. Reproduced with permission from [18]. 
(C) Osteochondral autograft transfer. On the left panel, blue-shaded regions that are recommended as graft 
donor sites on the femoral articular cartilage. On the middle panel, illustration of the range of motion of the joint 
after grafting that is tested to insure proper fixation and congruent resurfacing on the grafts. In the right panel, 
photo of a mosaicplasty performed on the femoral trochlea. Reproduced with permission from [20].
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tage of such solid scaffolds or matrices is that they have 
adequate mechanical properties compared with other 
systems such as hydrogels, and thus are able to support 
the physiological load present in the knee. Moreover, 
the solid scaffold will also be able to transmit the load 
to the subchondral bone.
The disadvantage of an AMIC approach is that most 
scaffolds promote cell spreading, which encourages 
www.futuremedicine.com 2897
Figure 4. Choice of the surgical treatment depending of the defect size, as recommended by Bekkers et al. in their 
systemic review [31].
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fibrous matrix production [41]. While it is recognized 
that AMIC may not produce tissue that is identical to 
that of native cartilage, however the neoformed tissue 
may prevent further deterioration, resulting in clinical 
improvements for the patient. An extensive review on 
scaffold-based clinical studies repair for cartilage can 
be found on the following reference [42].
Hydrogels
As an alternative to solid scaffolds, diverse hydro-
gels (Table 5) are now investigated for AMIC 
approaches [43]. They consist of crosslinked hydro-
philic polymer networks having the attractive feature 
of being minimal-invasively injected as a solution and 
capable to polymerize in situ. Crosslinking methods 
include light irradiation, temperature modulation and 
pH alteration [33]. Hydrogels used for chondrogenesis 
can be naturally-derived such as agarose [44,45], col-
lagen [46,47], fibrin [48,49], alginate [50–52] and hyal-
uronan [53]; or derive from synthetic polymers such 
as polyethylene glycols hydrogels [54,55]. Some stud-
ies have shown that less crosslinked (softer) hydro-
gels produce dynamic loading that might favor MSC 
chondrogenesis [56,57].
In comparison to solid scaffolds, hydrogels allow 
cells to have a more round morphology, characteristic 
of the chondrogenic phenotype, which reduces the for-
mation of fibrous tissues [58]. Nevertheless, hydrogels 
have limited mechanical properties, and then more 
prone to failure, which is a main disadvantage as artic-
ular cartilage is subject to high mechanical loads. Also, 
these types of material still have deficiency in their 
ability to integrate with the surrounding tissues.
Depending on the chosen surgical technique, it 
would be judicious to use one or the other material. 
Hence, solid scaffolds would be recommended for 
a MACI approach while a hydrogel would be more 
favorable for an AMIC approach, since usually MF are 
recommended for small defects. In this latter situation, 
hydrogels have less chance to fail upon implantation 
because of their weak mechanical properties.
Improvement strategies
As already mentioned, it has been shown that ACI has 
favorable results with 73.5% success at mean 12.8 years 
post surgery [34]. However ACI cannot be a universal 
gold standard treatment as the remaining 26% of the 
patients have shown worse final outcome, especially in 
cases where patients had bipolar lesions. Furthermore, 
the success of the ACI interventions was established 
on clinical scores based on questionnaires sent to 341 
patients, assessing the pain relief but not the quality of 
the newly formed cartilage, and the study did not have 
any preoperative values for any of the patients. Indeed, 
researchers and surgeons do not have the same focus, 
since the first looks for a symptom relief while the sec-
ond aims to recreate preinjury joint tissue, required for 
a long-term healing. Furthermore, the use of bioma-
terials in MACI and AMIC interventions gives good 
clinical results but does not necessarily improve the 
quality of the neoformed cartilage. In this section, 
we present some research directions and advances for 
inducing joints to have the biological capacity of long-
term healing, and thus further improve the outcome of 
the currents surgical treatments.
Evolution of biomaterials platforms
Functionalization of the implanted biomaterials
As seen, several biomaterial platforms have been tested 
for cartilage repair, either hydrogels or solid scaf-
folds. A first approach for improving cartilage repair 
is to improve the integration of the biomaterials used. 
Indeed, the use of sutures to fix the implanted matrix 
may destroy the adjacent cartilage, which is not opti-
mal for the cartilage regeneration. Equally, current tis-
sue adhesive, such as cyanoacrylates and fibrin glue, 
have poor biocompatibility properties and insufficient 
bonding strength.
In the laboratory stage of development, hydrogels 
are being modified to include adhesive properties for 
an increased integration in the tissue [58–60]. Thus, 
for a better adhesion to the host cartilage, Wang et 
al. have functionalized chondroitin sulfate polysac-
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charides with methacrylate and aldehyde groups to 
covalently link the cartilage proteins with the polyeth-
ylene glycols-based hydrogel they developed [58]. They 
have tested their material in chondral defects (3.2 mm 
diameter) in the femoropatellar groove of New Zea-
land white rabbits, and they have shown that with 
their multifunctional approach they can induce carti-
lage repair with a mechanical stability. Similarly, solid 
scaffolds made of poly(vinyl alcohol) were functional-
ized using a sequential process resulting in reactive car-
bonate groups on their surface, which can covalently 
bond with any amino group of the adjacent cartilage 
and thus increase interfacial strength by a factor of 
three [61].
Another strategy to enhance lateral integration to 
cartilage is to include antiapoptosis agents to relieve 
cell death at the defect edge [62]. In this case, the num-
ber of viable cells at the defect edge prevents matrix 
loss, and implies significant cartilage–cartilage inte-
gration. This approach has been tested in vitro with 
bovine cartilage discs where the inner core was cut but 
left in situ to create disc-ring composites and cultured 
up to 6 weeks with/without necrosis inhibitors [62].
Alternative strategy to improve cartilage integra-
tion and interfacial strength is to use matrix-degrading 
enzymes to decrease ECM antiadhesive properties [63]. 
The treatment with hyaluronidase and collagenase 
exposes the cells at higher density at the wound edges, 
and then more prone to deposit ECM resulting to an 
enhanced bonding with grafts and thus better integra-
tion [64]. However, so far this technique still remains at 
the level of basic research and to our knowledge did not 
have any clinical follow-up.
Improvements of cartilage grafts with 
biomechanics
An alternative approach to regenerate cartilage, espe-
cially for larger defects, is to culture cartilage grafts in 
bioreactor systems for an ex vivo growth and matura-
tion of the grafts before implantation in patients [65]. A 
method to enhance the mechanical properties and mat-
uration of grafts is to apply a mechanical stimulation to 
the developing tissue before the surgical application [66]. 
Indeed, it has been shown that uniaxial compression can 
favor chondrogenesis by upregulating collagen type II 
and aggrecan expression [67–72]. Dynamic compression 
increases likewise glycosaminoglycans deposition [73] 
and improves the compressive modulus of cartilage 
grafts [74]. The motivation of using such compressive 
loading comes from the fact that cartilage deformation 
up to 15% occurs during direct contact between joint 
surfaces during normal daily movements, such as walk-
ing [75]. Most of the studies relating a dynamic com-
pression used frequencies in the range of 0.01 to 1 Hz 
with strains of 10, 15 or 20% [76]. A recent study has 
shown that frequency and amplitude of stimulation can 
alter the chondrogenic response of human bone marrow 
mesenchymal stem cells with maximum expression of 
collagen type 2 and aggrecan at the highest frequency of 
1 Hz and maximal strain amplitude of 20% [77]. Never-
theless, particular frequency and amplitude of stimula-
tion may imply a cell response in a specific scaffold that 
Table 2. Cell-based product commercially available and used in clinics.
Product name Company Description
MACI Genzyme_sanofi Bilayer collagen I/III matrix
CAIS DePuy Mitek 35% polycaprolactone, 65% polyglycolic acid
ACI Orthocell Autologous chondrocytes
INSTRUCT CellCoTec Autologous chondrocytes with an integrated kit
Carticel Genzyme Periosteal flap
DeNovo ET ISTO Technologies Juvenile cartilage implant
Regenexx procedures Centeno-Schultz Clinic Adult stem cells and blood platelet treatment
RepliCart Mesoblast Adult stem cells
OrthoCyte Biotime Human embryonic progenitor cell lines
ChondroCelect TiGenix NV Autologous chondrocytes
NeoCart Histogenics Autologous chondrocytes in collagen I scaffold, for 
forming a cartilage before implantation
ChondronTM RMS Regrow® Lab Gel-type autologous chondrocytes
Bioseed C BioTissue AG Autologous chondrocytes grafts
Hyalograft-C Anika Therapeutics Autologous chondrocytes grafts
Biocart II Prochon Biotech Fibrin-hyaluronan
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would be different in another one, because the mecha-
notransduction in engineered cartilage may vary sub-
stantially between different biomaterials platforms [78] 
as they do not have the same cell-matrix interaction [47]. 
Thus, it has recently been proposed that energy dissipa-
tion due to a compressive loading might be considered 
as an overarching variable for optimizing the mechani-
cal stimulation for an enhanced chondrogenesis, as the 
dissipation encompasses all of the transient fluid- and 
solid-related physical phenomena occurring subsequent 
to a dynamic mechanical stimulation [79]. In particu-
lar, it has been shown that energy dissipation occurs in 
cartilage tissue and in biomaterials as they have visco-
elastic properties [80], and this dissipation is produced 
as heat, which in turn increases temperature in carti-
lage tissue [81,82]. This temperature increase subsequent 
to a mechanical stimulation has a beneficial effect on 
chondrogenic expression [83], implying thus the dissipa-
tion as a thermo-mechanical variable to consider for the 
optimization of bioreactor systems. However, no stud-
ies have been performed to assess the beneficial effect 
of a mechanical stimulation compared with improved 
biomaterials.
Drug delivery systems
Another alternative technique to improve cartilage 
repair is to increase the regenerative potential of the 
biomaterial platforms. Hence, efforts are implemented 
in research laboratories to modify those biomaterial 
platforms to incorporate growth factors and other 
molecules so as to enhance the regeneration process 
through increased recruitment and differentiation of 
endogenous progenitor cells [84,85]. It has been shown 
that TGF-β3 can be combined with a porous colla-
gen-scaffold to attract stem cells through chemotaxis 
and to resurface an entire joint in a rabbit [85]. In their 
study, Lee et al. have shown that TGF-β3 released 
from the scaffold recruited approximately 130% more 
cells in the regenerated cartilage than did spontaneous 
cell migration without TGF-β3, suggesting that joint 
resurfacing does not require cell delivery. Also, hydro-
gels are especially appropriate for such modifications as 
they are easily tunable for adding bioactive molecules. 
So a self-assembling system of amphiphile molecules 
designed to form nanofibers and having binding epi-
topes to TGF-β1 has been developed [86]. The slow 
release of the growth factor promoted the regenera-
tion of cartilage. Similarly, such self-assembly struc-
tures were engineered in a manner to attenuate local 
inflammation and therefore temper further cartilage 
degeneration [87].
A composite hydrogel has been developed to 
mechanically control the release of growth factors in 
cartilage in order to simultaneously couple the drug 
Table 3. Diverse cell sources used for cartilage repair.
Cell type Advantages Pitfalls
Autologous chondrocytes Native phenotype Small initial cell number
 Minimal risk of immunological 
problem
Dedifferentiation on expansion
  Morbidity on the donor site
  Double surgery for harvesting and 
implanting the cells
Allogeneic chondrocytes Larger cell number Limited donor availability
 Off-the-shelf solution Risk of disease transmission
Adult mesenchymal stem 
cells
Potential to produce large numbers Potential for hypertrophy
 Various harvest sites Heterogeneous population of cells
 Additional paracrine signaling 
potential
Stable and reproducible differentiation 
still problematic
Induced pluripotent stem 
cells
Large source of patient-specific cells Stable and reproducible differentiation 
still problematic
 Multiple cell types can be produced Potential for teratoma
Embryonic stem cells Off-the-shelf solution Stable and reproducible differentiation 
still problematic
 Multiple cell types can be produced Potential for teratoma
  Ethical considerations
????????????????[8]?
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delivery with cell receptors activation, which is essen-
tial for an enhancement of the tissue regeneration [88]. 
Indeed, mechanical loading has been shown to acti-
vate cell receptors to growth factors involved in the 
regeneration of cartilage [89–91], therefore a temporally 
adapted delivery induces maximum potency of the 
drug.
Nonetheless, it has to be mentioned that the addi-
tion of growth factors could have deleterious effects 
on cartilage when exceeding a certain amount, such 
as marked hyperplasia of the synovium and chondro-
osteophyte formation [92]. Thus the use of growth fac-
tors still requires several tests to determine the best 
concentration inducing only positive effect. More-
over, the addition of any biological components, such 
as growth factors, might be a barrier in the transla-
tion into clinics as it will involve greater examination 
than would be for the deliver materials alone. This 
will considerably complicate the regulatory process. 
Indeed, the regulatory agencies would consider many 
of the functionalized biomaterials as a combination 
product, where each component may need to be tested 
separately and in combination for its safety. Hence, 
the time and costs associated with the development 
and the translation of those new platforms should be 
well estimated according to the benefits of adding 
soluble factors.
Scaffold-free approaches
In order to overcome the challenges associated with 
scaffold use, scaffold-free techniques promoting the 
formation of biomechanically functional neocartilage 
without using scaffolds have been proposed [5,93–94]. 
Initially scaffold-free techniques were used to form 
small spherical aggregates of cells, for instance, by 
centrifugation, to study chondrogenesis. Indeed, with 
this process a reminiscence of mesenchymal conden-
sation during cartilage development occurs involving 
cell–cell and cell–matrix interactions, which results in 
collagen VI deposition around chondrocytes and col-
lagen II throughout the micro-tissue. Moreover, as this 
technique allows the cells to take a rounded morphol-
ogy favorable for a chondrogenic phenotype [95], recent 
research has expanded it to the generation of cartilage 
constructs [96]. Ofek et al. have developed a technique, 
in which chondrocytes are presented only to nonad-
herent surfaces to allow cells’ self-assembly driven 
by free energy minimization. The neoformed tissue 
shows gross morphological, histological, biochemical 
and biomechanical similarities to native cartilage after 
4 weeks [97]. Alternatively, cells can be expanded in 
monolayer up to a high confluence, in order to produce 
sufficient ECM to form a cohesive sheet that is lifted 
from the substrate as a whole [98]. Released cell sheets 
can then be rolled, layered or draped over molds [99].
Table 4. Solid scaffolds commercially available and used in clinics for autologous matrix-induced 
chondrogenesis procedures.
Product name Company Description
Agili-CTM CartiHeal Ltd Modified aragonite and hyaluronic acid
CaReS Arthro Kinetics Collagen type I matrix (with or without cells)
Chondro-Gide Geistlich Bilayer collagen I/III matrix
Novocart® Basic TETEC AG Biphasic 3D collagenous matrix
Chondrotissue BioTissue AG PGLA fleece with hyaluronic acid
Hyalofast Anika Therapeutics A benzyl ester of hyaluronic acid
TruFit Smith & Nephew Calcium sulphate/PLLA composite
Maix Matricel Collagen
MaioRegen JRI Orthopedics Ltd Deantigenated type I equine collagen with a lower layer mostly 
composed of magnesium-enriched hydroxyapatite
Table 5. Hydrogels commercially available and used in clinics for autologous matrix-induced 
chondrogenesis procedures.
Product name Company Description
CartiPatch TBF Tissue Engineering Agarose-alginate hydrogel
ChonDux Biomet Photopolymerized PEG
GelrinC Regentis PEG/fibrin
BST-CarGel Piramal Life Sciences Chitosan-based hydrogel
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Direct culture of bone marrow stromal cells on 
porous polyphosphate substrates allowed developing 
scaffold-free osteochondral constructs having a bipha-
sic structure with a calcified zone in cartilage [100,101]. 
However, in a scaffold-free method it is important to 
keep the neoformed tissue long enough in culture so 
that it is mature to sustain the mechanical loading 
when implanted.
Higher ECM content and mechanical proper-
ties have been generated in cartilaginous tissues 
without scaffolds when compared with scaffold-
based approach [102,103]. Currently, scaffold-free 
technologies [37,104] are undergoing clinical trials [6].
To form a neocartilage tissue, a scaffold-free method 
necessitates a large number of cells compared with a 
scaffold-based approach as the exogenous biomaterial 
is missing. Autologous cells remain the best option for 
a clinical translation, but they show limitations with 
the number of primary cells available and morbidity of 
the donor site [99]. Therefore further investigations are 
dedicated to find alternative cells source. Thus, Dar-
wiche et al. propose epiphyseal chondroprogenitors 
as a stable cell source for cartilage cell therapy [105]. 
Indeed, extraordinary ability for self-repair has 
been shown by fetal cartilage cells [106], as well as an 
immune-modulatory activity [107,108].
Because of the immunological profile and their 
prededicated differentiation phenotype, epiphyseal 
chondroprogenitors would show superior stability in 
withstanding environmental variability over the quasi-
quiescent adult chondrocytes, and present over stem 
cells an interesting potential for allogeneic cell source 
in tissue-engineering applications.
Alternative strategy to improve cartilage tissue engi-
neering without altering the biomaterials would also 
be to use genetically modified cells. Indeed, it has 
been shown that transfected chondrocytes induced 
to express TGF-β1 enhance cartilage formation [109]. 
Nevertheless, no study has been performed to com-
pare the efficacy between a scaffold-free approach and 
functionalized scaffolds. But here again, the hurdle 
of the regulatory process has to be considered in the 
development of gene therapies.
Conclusion
Research advances in biomaterials with promising 
in vivo results open new perspectives in the develop-
ment of cartilage repair approaches, but the advan-
tage of these new strategies compared with established 
cartilage repair techniques is not yet established in 
clinics. Likewise, the potential of using scaffold-free 
approaches by harnessing the potential of progenitor 
cells, or other allogeneic cells source, to create orga-
nized hyaline-like repair tissue in situ remains hypoth-
esis to verify. Would it be possible one day that scien-
tists could harness biology and recapitulate or engineer 
the simplest tissues of the body such as cartilage? Long-
term follow-up and more comparative systematic trials 
are required to establish the best method for cartilage 
regeneration. Also, in tissue engineering the regulatory 
process is pivotal, and should be one of the first aspects 
considered in the development of new strategies in 
general and in biomaterial platforms in particular.
Future perspective
The constantly increasing number of publications and 
products development for cartilage repair reflects the 
interest and technological advances in the field. How-
ever, cartilage repair still remains deficient to some 
extent and its market still is to be conquered. Advances 
Executive summary
?? Despite diverse approaches, nowadays there is no treatment that is able to restore hyaline-like cartilage with 
native tissue characteristics.   
?? The current surgical techniques for the repair of articular cartilage are microfracture, autologous 
chondrocytes implantation and mosaicplasty.   
?? Randomized clinical trials have shown that none of the surgical technique is superior to the others over a 5 
years follow-up.   
?? Clinical products used in cartilage repair are cell-based matrices, solid scaffolds and hydrogels.   
?? Strategies to improve cartilage repair are to develop biomaterials such as to functionalize the implanted 
biomaterial platforms to have a better integration in the tissue; to enhance the tissue formation and matrix 
organization in the cartilage grafts thanks to mechanical stimulation prior to implantation; to locally deliver 
growth factors or drugs by the means of the implanted materials and scaffold-free approaches, such as 
allogeneic cell sources and gene therapies.   
?? Research advances in biomaterials with promising in vivo results open new perspectives in the development of 
cartilage repair approaches, but the advantage of these new strategies compared with established cartilage 
repair techniques is not yet established in clinics.   
?? The regulatory process is pivotal and should be one of the first aspects considered in the development of a 
new cartilage repair strategy in general and in biomaterial platforms in particular.
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in basic research for cartilage repair should lead to 
improved clinical therapies, however their success will 
be depending on their capability to simplifying the 
surgical procedures and to enhance the tissue regenera-
tion. Finally, only the well designed prospective clini-
cal studies will dictate the survival of a novel therapy 
by validating and comparing its efficacy to existing 
therapies and will allow overcoming the regulation 
process.
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